SUWANEE, GA--(Marketwired - Sep 21, 2017) - SANUWAVE Health, Inc. (
Company management will be available for meetings with past and current clinical investigators who participated in the two Diabetic Foot Ulcer studies conducted by SANWAUVE to discuss the results and to develop publication strategies. In addition, SANWUAVE will be working with these investigators as well as recruiting new investigators for our future clinical investigation plans. Company management will also be available for one-on-one meetings with investors participating in the conferences. For those who would like to schedule an appointment with SANUWAVE's management, please contact Kevin Richardson II at 978-922-2447 or via email at investorrelations@sanuwave.com.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company's product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company's ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
For additional information about the Company, visit www.sanuwave.com.
Contact Information:
Millennium Park Capital LLC
Christopher Wynne
312-724-7845
cwynne@mparkcm.com
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman of the Board
978-922-2447
investorrelations@sanuwave.com